Opsoclonus-myoclonus syndrome (Kinsbourne’s syndrome)
https://doi.org/10.20538/1682-0363-2019-4-233-238
Abstract
About the Authors
V. M. AlifirovaRussian Federation
DM, Professor, Head of the Department of Neurology and Neurosurgery,
2, Moscow Trakt, Tomsk, 634050
T. A. Valikova
Russian Federation
PhD, Associate Professor, Department of Neurology and Neurosurgery,
2, Moscow Trakt, Tomsk, 634050
N. V. Pugachenko
Russian Federation
PhD, Associate Professor, Department of Neurology and Neurosurgery,
2, Moscow Trakt, Tomsk, 634050
N. V. Kubar
Russian Federation
Nevrologist, Department of Neurology,
96, Ivana Chernykh Str., Tomsk, 634063
M. N. Azhermacheva
Russian Federation
PhD, Associate Professor, Department of Neurology and Neurosurgery,
2, Moscow Trakt, Tomsk, 634050
N. B. Vershinina
Russian Federation
Nevrologist, Chief of the Department of Neurology,
96, Ivana Chernykh Str., Tomsk, 634063
S. D. Kazakov
Russian Federation
Post-Graduate Student, Department of Neurology and Neurosurgery,
2, Moscow Trakt, Tomsk, 634050
E. S. Koroleva
Russian Federation
PhD, Associate Professor, Department of Neurology and Neurosurgery,
2, Moscow Trakt, Tomsk, 634050
References
1. Shnayder N.A., Kantimirova E.A., Ezhikova V.A. Opsoclonus-myoclonus syndrome. Neuromuscular Diseases. 2013; 3: 22–26 (in Russ.).
2. Bembeeva R.Ts., Petrukhin A.S., Bologoye А.А., Baydun L.V., Ilyina E.S., Samoylova M.V., Kolpakchi L.M., Semykina L.I., Fedonyuk I.D. Opsoclonus-myoclonus syndrome in children. S.S. Korsakov Journal Nevrology and Psychiatry. 2007; 2: 4–11 (in Russ.).
3. Ilyina E.S., Bobylova M.Yu. Kinsbourne’s syndrome or opsoclonusmyoclonus syndrome in childhood. Lechashhij Vrach. 2006; 5: 36–38 (in Russ.).
4. Petrukhin A.S., Bembeeva R.Ts., Samoylova M.V. Diagnosis of paraneoplastic opsoclonus-myoclonus syndrome in children. S.S. Korsakov Journal Nevrology and Psychiatry. 2006; 2: 63–66 (in Russ.).
5. Glatz K., Meinck H.M., Wildemann В. Parainfectious opsoclonus-myoclonus syndrome: high dose intravenous immunoglobulins are effective. J. Neurol. Neurosurg. Рsy-chiat. 2003; 74 (2): 279–280. DOI: 10.1136/jnnp.74.2.279.
6. Pranzatelli M.R., Travelstead A.L., Tate E.D. et al. B- and T-cell markers in opsoclonus-myoclonus syndrome. Neurology. 2004; 62 (9): 1526–1532. DOI: 10.1212/wnl.62.9.1526.
7. Pranzatelli M.R. Opsoclonus-myoclonus syndrome: diagnostic and therapeutic considerations. Neuropediatrics. 2004; 35: 146–148.
8. Pranzatelli M.R., Tate E.D., Travelstead A.L., Longee D. Immunologic and clinical responses to rituximab in a child with opsoclonus-myoclonus syndrome. Pediatrics. 2005; 115 (1): 1: е115–119. DOI: 10.1542/peds.2004-0845.
9. Tate E.D., Allison T.J., Pranzatelli M.R., Verhulst S.J. euroepidemiologic trends in 105 US cases of pediatric оpsoclonus-myoclonus syndrome. J. Pediat. Oncol. Nursing. 2005; 22 (1): 8–19. DOI: 10.1177/1043454204272560.
Review
For citations:
Alifirova V.M., Valikova T.A., Pugachenko N.V., Kubar N.V., Azhermacheva M.N., Vershinina N.B., Kazakov S.D., Koroleva E.S. Opsoclonus-myoclonus syndrome (Kinsbourne’s syndrome). Bulletin of Siberian Medicine. 2019;18(4):233-238. (In Russ.) https://doi.org/10.20538/1682-0363-2019-4-233-238